Tzeng et al., 2015 - Google Patents
An ideal PPAR response element bound to and activated by PPARαTzeng et al., 2015
View HTML- Document ID
- 14064770573620264257
- Author
- Tzeng J
- Byun J
- Park J
- Yamamoto T
- Schesing K
- Tian B
- Sadoshima J
- Oka S
- Publication year
- Publication venue
- PLoS One
External Links
Snippet
Peroxisome proliferator-activated receptor-α (PPARα), a nuclear receptor, plays an important role in the transcription of genes involved in fatty acid metabolism through heterodimerization with the retinoid x receptor (RXR). The consensus sequence of the PPAR …
- 108010028924 PPAR alpha 0 title abstract description 287
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tzeng et al. | An ideal PPAR response element bound to and activated by PPARα | |
Jang et al. | SREBP1c-CRY1 signalling represses hepatic glucose production by promoting FOXO1 degradation during refeeding | |
Wu et al. | Novel mechanism of Foxo1 phosphorylation in glucagon signaling in control of glucose homeostasis | |
Cai et al. | Domain-dependent effects of insulin and IGF-1 receptors on signalling and gene expression | |
Jiang et al. | IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling | |
Masuyama et al. | Calcium/calmodulin‐signaling supports TRPV4 activation in osteoclasts and regulates bone mass | |
Lee et al. | Cyclin D1–Cdk4 controls glucose metabolism independently of cell cycle progression | |
De Fabiani et al. | Coordinated control of cholesterol catabolism to bile acids and of gluconeogenesis via a novel mechanism of transcription regulation linked to the fasted-to-fed cycle | |
Lin et al. | Hyperlipidemic effects of dietary saturated fats mediated through PGC-1β coactivation of SREBP | |
Bragança et al. | Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2 | |
Yang et al. | ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology: implication for Coffin-Lowry syndrome | |
Lu et al. | Metabolic crosstalk: molecular links between glycogen and lipid metabolism in obesity | |
Xie et al. | Down-regulation of hepatic HNF4α gene expression during hyperinsulinemia via SREBPs | |
Dang et al. | Fasting and feeding signals control the oscillatory expression of Angptl8 to modulate lipid metabolism | |
Gelderloos et al. | A role for Src in signal relay by the platelet-derived growth factor α receptor | |
Hoggatt et al. | The transcription factor Foxf1 binds to serum response factor and myocardin to regulate gene transcription in visceral smooth muscle cells | |
Lu et al. | ER alpha rapid signaling is required for estrogen induced proliferation and migration of vascular endothelial cells | |
Wang et al. | CARM1/PRMT4 is necessary for the glycogen gene expression programme in skeletal muscle cells | |
Chen et al. | Hepatic activation of the FAM3C-HSF1-CaM pathway attenuates hyperglycemia of obese diabetic mice | |
Canettieri et al. | Dual role of the coactivator TORC2 in modulating hepatic glucose output and insulin signaling | |
Yang et al. | A novel small molecule activator of nuclear receptor SHP inhibits HCC cell migration via suppressing Ccl2 | |
Wagner et al. | Peroxisome proliferator-activated receptor β stimulation induces rapid cardiac growth and angiogenesis via direct activation of calcineurin | |
Meng et al. | Identification of HNF-4α as a key transcription factor to promote ChREBP expression in response to glucose | |
Defour et al. | Sirtuin 1 regulates SREBP-1c expression in a LXR-dependent manner in skeletal muscle | |
Ishizaka et al. | Double plant homeodomain (PHD) finger proteins DPF3a and-3b are required as transcriptional co-activators in SWI/SNF complex-dependent activation of NF-κB RelA/p50 heterodimer |